In the Journals

Improved treatment strategies reduce colectomy in pediatric ulcerative colitis

April 24, 2019
The addition of biologics and using an early step-up approach to therapy has helped improve outcomes among children with ulcerative colitis over the…
In the Journals

‘Every patient, every time’: Inpatient protocol standardizes ulcerative colitis care

April 17, 2019
Since implementing its Inpatient Ulcerative Colitis Protocol in 2016, the University of California San Francisco has improved the uniform application…
In the JournalsPerspective

Entyvio ‘should be’ first choice for patients with UC who previously failed Remicade

April 1, 2019
In a direct comparison with Humira, Entyvio won out as the top choice for second line therapy for patients with ulcerative colitis who failed therapy…
In the Journals

Risk for EoE higher in patients with IBD, and vice versa

March 29, 2019
Eosinophilic esophagitis and inflammatory bowel disease have a connection in which patients with one are at higher risk for the other, according to…
Meeting News

UNIFI: Stelara achieves long-term remission in ulcerative colitis

March 28, 2019
Two different dosing regimens of Stelara helped patients with moderate-to-severe ulcerative colitis achieve clinical remission and maintain a…
In the Journals

1-in-3 patients with IBD prescribed treatments off-label

March 26, 2019
Roughly one-fifth of all prescriptions for inflammatory bowel disease are considered “off-label” with one-third of all patients receiving…

First patient dosed in moderate, severe ulcerative colitis trial

March 23, 2019
Theravance Biopharma has announced the first patient dosing in a phase 2b/3 study of TD-1473 in patients with moderately to severely active…
In the Journals

Patients with IBD appear more receptive to text-based telemedicine

March 21, 2019
Lower attrition rates observed in a year-long study revealed that patients with inflammatory bowel disease are more receptive to an improved…
Meeting News

Intensive treatment within the first year prevents early Crohn’s progression

March 14, 2019
Patients with early Crohn’s disease who can achieve endoscopic or deep remission after one year of treatment are less likely to experience…
Meeting News

GEMINI: Entyvio safe long-term for Crohn’s, ulcerative colitis

March 13, 2019
Final results from the GEMINI trial revealed that Entyvio had a suitable safety profile for long-term treatment of inflammatory bowel disease…